Sign In
Buy FDMT
$9.53
+0.260 (+2.80%)
At Close: Jun 03, 2026
4D Molecular Therapeutics, Inc. (FDMT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
03:30pm, Friday, 26'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Ther
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co
The Schall Law Firm Invites FDMT Investors To Join The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.
04:00pm, Thursday, 25'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Ther
NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. (“
FDMT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of 4D Molecular Therapeutics, Inc. Shareholders Who Lost Money
10:30am, Thursday, 25'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp
Lost Money on 4D Molecular Therapeutics, Inc.(FDMT)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
03:45pm, Wednesday, 24'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co
The Schall Law Firm Invites FDMT Investors To Join The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.
03:00pm, Wednesday, 24'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Ther
FDMT ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your 4D Molecular Therapeutics, Inc. investment
10:30am, Wednesday, 24'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. ("4D Molecular" or "the Comp
4D Molecular Therapeutics, Inc. (FDMT) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
06:15pm, Tuesday, 23'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics") (NASDAQ:FDMT) co
The Schall Law Firm Invites FDMT Investors To Participate In The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.
06:00pm, Tuesday, 23'rd Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Ther
